Business Description
Description
Financial Strength
9/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | No Debt | |||||
Equity-to-Asset | 0.78 | |||||
Interest Coverage | No Debt | |||||
Piotroski F-Score | 2/9 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year EBITDA Growth Rate | -91.6 | |||||
3-Year EPS without NRI Growth Rate | -91.6 | |||||
3-Year FCF Growth Rate | -80.7 | |||||
3-Year Book Growth Rate | 49.5 |
Momentum Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 56.02 | |||||
9-Day RSI | 54.56 | |||||
14-Day RSI | 52.3 | |||||
6-1 Month Momentum % | 2.94 | |||||
12-1 Month Momentum % | 12.9 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 1.26 | |||||
Quick Ratio | 1.26 | |||||
Cash Ratio | 0.83 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -7.3 | |||||
Shareholder Yield % | -10.1 |
Profitability Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
ROE % | -161.66 | |||||
ROA % | -130.6 | |||||
ROIC % | -471.12 | |||||
ROCE % | -161.65 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PB Ratio | 8.84 | |||||
Price-to-Tangible-Book | 12.83 | |||||
EV-to-EBIT | -3.46 | |||||
EV-to-EBITDA | -3.46 | |||||
EV-to-FCF | -3.83 | |||||
Earnings Yield (Greenblatt) % | -28.89 | |||||
FCF Yield % | -24.54 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Abera Bioscience AB Executives
DetailsGF Value
Analyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil €) | |||
EPS (TTM) (€) | -0.067 | ||
Beta | 1.17 | ||
Volatility % | 57.97 | ||
14-Day RSI | 52.3 | ||
14-Day ATR (€) | 0.028145 | ||
20-Day SMA (€) | 0.3692 | ||
12-1 Month Momentum % | 12.9 | ||
52-Week Range (€) | 0.246 - 0.514 | ||
Shares Outstanding (Mil) | 14.46 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 2 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Abera Bioscience AB Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Abera Bioscience AB Stock Events
Event | Date | Price(€) | ||
---|---|---|---|---|
No Event Data |
Abera Bioscience AB Frequently Asked Questions
What is Abera Bioscience AB(FRA:8WK)'s stock price today?
When is next earnings date of Abera Bioscience AB(FRA:8WK)?
Does Abera Bioscience AB(FRA:8WK) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |